Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Lithium Hydroxide | HCID 3939 | — |
| Reactant | PyBOP | HCID 2724699 | — |
| Reactant | HCID 89783614 | HCID 89783614 | — |
| Solvent | Hydrochloric Acid | HCID 313 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 89784159 | HCID 89784159 | 23.7% |
Reaction Steps
A solution of ethyl 5-(3-(cyclopropylamino)-6-fluoro-2-methylquinoxalin-5-yl)-2-((5S,6S)-2,2,3,3,5,10,10-heptamethyl-8-oxo-4,9-dioxa-7-aza-3-silaundecan-6-yl)-1H-pyrrole-3-carboxylate (353b) (2.43 g, 3.79 mmol) in 1,4-dioxane (40 mL) was treated with 1.0 M aq. LiOH (19 mL, 19 mmol). The resulting orange solution was stirred at RT for 16 h. The mixture was then heated at 85° C. for 6 h, and then at 65° C. for 64 h. The resulting suspension was concentrated to give a dark solid. Then solid was dissolved in a 4.0 M solution of HCl in 1,4-dioxane (20 mL). The resulting dark red solution was stirred at RT for 45 min. The mixture was concentrated and the dark red residue containing 354c was dissolved in a mixture of 1,4-dioxane (20 mL) and water (10 mL). TEA (1.2 mL, 8 mmol) was added and the mixture was lyophilized to give a brown solid. A solution of the brown solid in DMF (40 mL) was treated with TEA (2.64 mL, 18.94 mmol) followed by PyBOP (NovaBiochem) (3.94 g, 7.57 mmol). The mixture was stirred at RT for 1 h. The mixture was concentrated and water (100 mL) was added. A brown gum separated out. The mixture was stirred and heated at 100° C. for 1 h, and then cooled in an ice-water bath. Saturated aq. NaHCO3 (5 mL) was added and the mixture was stirred for 15 min. The aq. layer was decanted from the flask (product adhered to the sides of the vessel), and the product was washed with water (10 mL). The product was dissolved in 1,4-dioxane (25 mL), filtered, and concentrated. The resulting gum was dissolved in DMSO (10 mL) and purified by preparative HPLC (Gradient: 10-100% MeCN in H2O, modified with 0.1% TFA). The major product was concentrated, neutralized with 2 M NH3 in MeOH, and lyophilized from 1,4-dioxane to give (S)-2-(3-(cyclopropylamino)-6-fluoro-2-methylquinoxalin-5-yl)-6-((S)-1-hydroxyethyl)-5,6-dihydropyrrolo[3,4-b]pyrrol-4(1H)-one (353) (342 mg) as a yellow solid. LC-MS m/z 382.0, [M+H]+; 19F NMR (DMSO-d6; 376 MHz): δ −108.03 (s, 1F). A slower eluting minor product was also isolated from the preparative HPLC. This product was concentrated, neutralized with 2 M NH3 in MeOH, and lyophilized from 1,4-dioxane to give (R)-2-(3-(cyclopropylamino)-6-fluoro-2-methylquinoxalin-5-yl)-6-((S)-1-hydroxyethyl)-5,6-dihydropyrrolo[3,4-b]pyrrol-4(1H)-one (354) (29 mg) as a yellow solid. LC-MS m/z 382.0, [M+H]+; 19F NMR (DMSO-d6; 376 MHz): δ −108.79 (s, 1F).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09394297B2 |
|---|
| Source dataset | uspto-grants-2016_07 |
|---|
| ORD ID | ord-e601bf999fec428a80e009ec34b51268 |
|---|
| Source note | uspto-grants-2016_07 |
|---|